Australia Medical Oxygen Concentrator Market- By Product (Portable Oxygen Concentrator and Stationary Oxygen Concentrator); By Technology (Continuous Dose and Pulse Dose); By Application (Chronic Obstructive Pulmonary Disease, Asthma and Others); By End-User (Home care , Travel, Hospital and Clinic); By Region (New South Wales, Victoria, Queensland, Western Australia, South Australia, Australian Capital Territory, Tasmania and The Northern Territory); Trend Analysis, Competitive Market Share & Forecast, 2017-2027
- Published Date: April 2021
- Report ID: BWC20326
- Available Format: PDF
- Page: 168
Australia Medical Oxygen Concentrator Market- Industry Trends & Forecast Report 2026
The Australia medical oxygen concentrator market was worth USD 49.4 million in 2020. The market is further projected to reach USD 92.7 million by 2027, at a CAGR of 11.3% during the forecast period (2021-2027). This is due to advancements in technology and the growing prevalence of COPD in Australia. According to a report released by the Australian Bureau of Statistics and National Health Survey (NHS) on the self-reported prevalence of chronic respiratory conditions, approximately one-third (31%) of Australians suffered from chronic respiratory conditions in 2017-18. According to the report, Allergic rhinitis (hay fever) affected almost 19% (4.7 million) Australian population, asthma affected almost 11% (2.7 million) Australian population, chronic sinusitis affected almost 3.4% (2 million) population, and COPD (Chronic Obstructive Pulmonary Disease) affected 2.5% of the Australian population.
The National Drug Strategy Household Survey (NDSHS) estimated that 11.6% of adults in Australia smoked daily in 2019. According to the NDSHS, people in their 40s and 50s have the highest regular smoking rates, at 15.8% and 15.9% respectively. Tobacco smoking was the leading cause of health issues and deaths in Australia in 2018-19. Additionally, COPD was the fifth leading cause of deaths in Australia in 2018 with 7,113 deaths. COPD was identified as an associated cause of death in 11,385 deaths, with COPD being the primary cause of death in 7,113 deaths. Additionally, according to the Australian Institute of Health and Welfare also announced that the mortality rate for people aged 45 and over living in rural areas in Australia is nearly 1.9 times higher than the mortality rate for people aged 45 and over living in urban areas.
Source: BlueWeave Consulting
Australia Medical Oxygen Concentrator Market Overview
An oxygen concentrator is a form of medical device that delivers oxygen to people who have breathing problems. This device is used to substitute oxygen in people who have lower-than-normal oxygen levels in their blood. Filtering the ambient air, compressing it to the necessary density, and then supplying purified medical grade oxygen to the patient through a pulse-dose delivery system or continuous stream system is the function of oxygen concentrators.
It also has special filters and sieve beds that help eliminate nitrogen from the air, ensuring that the patient receives fully filtered oxygen. These devices also have an electronic user interface that allows users to change the oxygen concentration levels and distribution settings. The oxygen can then be inhaled through a nasal cannula or a special mask.
Australia Medical Oxygen Concentrator Market Forecast and Trends
Many government and non-government organizations have initiated programs and services to inform the public about COPD and how to handle it. For example, the National Heart, Lung, and Blood Institute (NHLBI) and the World Health Organization (WHO) founded the Global Initiative for Chronic Obstructive Lung Disease to raise COPD awareness and assist people with disease management.
Additionally, to raise COPD awareness, the Australian government launched the National Tobacco Strategy 2012–2018, a program to reduce tobacco-related harm in Australia. This strategy was endorsed by the health ministers to improve the health of all Australians by lowering the prevalence of smoking, as well as the associated health, social, and economic costs, and inequalities. In Australia, smoking rates are much higher in people from low socioeconomic groups, or those who are disabled, homeless, or imprisoned, and those who have a mental disorder or other drug or alcohol addiction. In Australia, tobacco remains a significant cause of death and disability. Around 3.3 million Australians still smoke and an estimated 15,000 people die each year as a result of smoking-related illnesses.
Oxygen therapy is gaining increasing acceptance in Australia but penetration of medical oxygen cylinders is very low. Patients still prefer using portable oxygen cylinders due to the associated high maintenance cost of oxygen concentrators. In terms of market share and consumer base, oxygen concentrators compete directly with oxygen cylinders, which have wide availability and provide highly pure oxygen. They also have low maintenance, require no electricity, and are quite reliable. On the other hand, oxygen concentrators require power to operate. Portable medical oxygen concentrators use batteries to turn oxygen from the air into compressed oxygen, while stationary medical oxygen concentrators use electricity. In case of mechanical failure in the medical oxygen cylinder or no availability of electricity, backup oxygen cylinders are necessary.
When a high flow rate of oxygen is required, the purity of oxygen suffers in medical oxygen concentrators. Apart from these factors, the requirement of regular maintenance, heat, noise, and vibration production are other associated issues with medical oxygen concentrators. Portable medical oxygen concentrators alleviate some of these problems, but they are very expensive. Also, portable medical oxygen cylinders are suitable for people with low oxygen requirements and are not suitable when continuous oxygen flow is required. Many businesses are trying to find a solution to the problems with medical oxygen concentrations described above as these issues are acting as a restraint for the growth of the medical oxygen concentrators market in Australia.
Impact of COVID-19 on Australia Medical Oxygen Concentrator Market
The World Health Organization (WHO) recently added oxygen to its List of Essential Medicines, considering its importance in the treatment of a variety of illnesses. This list outlines the “minimum medicine needs for a basic health-care system” to which people should have reliable and sufficient access. Around one in five COVID-19-infected patients require hospitalization and treatment with supplemental oxygen. For many, it’s the only treatment they’ll need, and usually only for a short duration.
However, due to the severity of the pandemic, oxygen demand has skyrocketed. The WHO estimates that more than half a million COVID-19 patients in low and middle-income countries need oxygen treatment every day. The Australia medical oxygen concentrator market is growing as a result of the ongoing pandemic. As COVID-19 is a respiratory disease, many people suffering from COVID-19 need medical oxygen supply to maintain the blood flow in the body. Until now, Australia has registered approximately 30,000 cases of COVID-19, resulting in increased demand from hospitals, causing the market to grow.
Australia Medical Oxygen Concentrator Market- By Product
Based on product, the Australia medical oxygen concentrators equipment and the rental market is segmented into portable oxygen concentrator and a stationary oxygen concentrator. The portable oxygen concentrator segment accounted for the largest share in 2020 and is likely to dominate the market during the forecast period. This growth can be attributed to the advantages provided by portable oxygen concentrators, such as their ease of use and the fact that elderly people can carry this equipment with them and use it effectively.
Source: BlueWeave Consulting
Australia Medical Oxygen Concentrator Market- By Technology
Based on technology, the Australia medical oxygen concentrators equipment and rental market is grouped into continuous dose and pulse dose. Continuous dose medical oxygen concentrator accounted for the largest share in the market in 2020. Continuous dose oxygen concentrators are approved by Federal Aviation Administration (FAA) which helps the individual to carry the equipment with them if they are traveling in or across the country. In addition, the devices are not fitted with any breath detection technology, hence they are cheaper as compared to pulse flow technology.
Additionally, pulse dose oxygen concentrator is also catching up as a faster-growing market segment as this technology is more effective as compared to continuous dose. This FAA-approved technology is largely used by individuals who are frequent air travelers.
Australia Medical Oxygen Concentrator Market- By Application
Based on application, Australia medical oxygen concentrator and rental market is segmented into COPD, asthma and others. COPD held the largest share in the market in 2020. COPD is among the most common respiratory disorder among the Australian population. One out of seven people aged above 40 in Australia suffers from this disease. In 2018, COPD was the 5th leading cause of death in Australia. The rising prevalence of these diseases in Australia has positively impacted the market growth for the medical oxygen concentrator.
Australia Medical Oxygen Concentrator Market- By End-User
Based on end-user, the Australia medical oxygen concentrator equipment and rental market is segmented into hospitals, clinics, home care, and travelers. The home care segment accounted for the largest share in the market in 2020. The growth of this segment is due to the increasing demand for home healthcare oxygen therapies, as well as the rising demand for pure oxygen and technical advances such as the miniaturization of these medical devices. The rapidly ageing population of Australia puts the country at risk for a number of respiratory and pulmonary diseases. The Australian population is ageing, according to the Australian Bureau of Statistics (ABS), with older Australians increasing in proportion to the overall population. In 2017, 15% of Australians (3.8 million) were aged 65 and over; this proportion is projected to grow steadily over the coming decades which likely to drive the market growth.
Australia Medical Oxygen Concentrator Market- By Region
Based on region, the Australia medical oxygen concentrators equipment market is segmented into New South Wales, Queensland, South Australia, Tasmania, Victoria, Western Australia, Australian Capital, and The Northern Territory. With a market share of 30.61%, New South Wales accounted for the largest share of the market. This growth can be attributed to the increasing expenditure in the medical and healthcare sector by the governments. Also, the increasing number of privately owned hospitals and clinics in this region drives the growth of the market for Australia medical oxygen equipment.
Source: BlueWeave Consulting
The Australia medical oxygen concentrator market has an established ecosystem comprising of some major companies in the market with a diversified portfolio of products. The Australia medical oxygen concentrator market is highly consolidated with a few players holding a larger share in the market, primarily in terms of equipment purchase. The key players in the market include Philips Respironics, Caire Inc., Invacare Corporation, Inogen, Inc., Drive Devilbiss Healthcare, Nidek Medical Products Inc., Sysmed (China) Co., Ltd, and others. These players have been adopting various natural and inorganic growth strategies like mergers & acquisitions, expansions, and recent product developments in the oxygen concentrators to increase the capitalization of market shares. The market players are increasingly working on adapting to the latest technologies to incorporate better measures to enhance the quality and performance of the oxygen concentrators at an affordable price for the customers.
· In January 2021, The SAROS 4000 Oxygen System, a portable oxygen concentrator developed exclusively for military use, has been launched by CAIRE Inc., a global oxygen therapy manufacturer.
· In August 2017, With the launch of the enhanced Invacare Platinum Mobile Oxygen Concentrator with Connectivity Invacare Corporation has expanded its healthcare informatics offering. This would be the company’s second application in healthcare informatics after the launch of LiNX technology on its new Invacare TDX SP2 power wheelchair.
Scope of Report
Historical data- 2017-2020
Base Year- 2021
Revenue in USD Million
New South Wales, Queensland, South Australia, Tasmania, Victoria, Western Australia, Australian Capital, and The Northern Territory
Product/ Service segmentation
By Product, By Technology, By Application, By End-User and by Region
Philips Respironics, Caire Inc., Invacare Corporation, Inogen, Inc., Drive Devilbiss Healthcare, Nidek Medical Products Inc., Sysmed (China) Co., Ltd, and others.
Ø Portable Oxygen Concentrator
Ø Stationary Oxygen Concentrator
Ø Continuous Dose
Ø Pulse Dose
Ø Chronic Obstructive Pulmonary Disease (COPD)
Ø Home care
Ø New South Wales
Ø South Australia
Ø Western Australia
Ø Australian Capital
Ø The Northern Territory
What is the current size of the Australia medical oxygen concentrator market?
Answer: The Australia medical oxygen concentrator market has reached USD 49.4 Million in 2020.
What are the major factors driving the growth of the Australia medical oxygen concentrator market?
Answer: The major factors propelling the growth of the Australia Medical Oxygen Concentrator market is growing prevalence of COPD in Australia.
Who are the key players in the Australia medical oxygen concentrator market?
Answer: The key players in the Australia medical oxygen concentrator market are Philips Respironics, Caire Inc., Invacare Corporation, Inogen, Inc., Drive Devilbiss Healthcare, Nidek Medical Products Inc., Sysmed (China) Co., Ltd, and others.
Which technology accounted for the largest share in the Australia medical oxygen concentrator market?
Answer: Continuous dose accounted for the largest share in the Australia medical oxygen concentrator market.
Which application is dominating the Australia medical oxygen concentrator market?
Answer: COPDs are dominating the Australia medical oxygen concentrator market.
- Global Automotive Simulation Market
- The Global Food Blenders and Mixers Market - Industry Trends & Forecast Report 2027
- The global Light Sensor Market witness market size of USD 1.30 Billion in 2019 and projected to reach USD 2.26 Billion by 2026
- The Global Antimicrobial Susceptibility Testing Market- Industry Trends & Forecast Report 2027
- Green Tea Market Report, 2019- 2025 | Global Research
WHY CHOOSE US
24/7 Research support
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Coustom Research Service
Ask the Analyst to customize an exclusive study to serve your research needs
Quality & Accuracy
Ask the Analyst to customize an exclusive study to serve your research needs
As the business world is changing dynamically every day. We need to stay pin point in relation to data management and optimum data utilization
We never share your personal and confidential information. Your personal information is safe and secure with us.